SUN PHARMACEUTICAL INDUSTRIES INC 2024-03-06 Health serious FDA
Health · FDA · Recall #FDA-D-0350-2024
Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle,… Recall
Issued March 6, 2024 · SUN PHARMACEUTICAL INDUSTRIES INC
In March 2024, SUN PHARMACEUTICAL INDUSTRIES INC recalled the Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle,…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Dissolution Specifications: Out of specification for dissolution.
What you should do
- 1 Stop using Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact SUN PHARMACEUTICAL INDUSTRIES INC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Health
- Recall date
- March 6, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the U.S.
- Recall number
- FDA-D-0350-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- SUN PHARMACEUTICAL INDUSTRIES INC has 34 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.